Actively Recruiting
Biomarker Discovery in Lung Cancer - Malaysia
Led by University of Malaya · Updated on 2024-07-18
400
Participants Needed
1
Research Sites
154 weeks
Total Duration
On this page
Sponsors
U
University of Malaya
Lead Sponsor
M
MiRXES Pte Ltd
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study aims to 1. Identify biomarkers and signatures to differentiate between high-risk and lung cancer patients. 2. Discover blood-based biomarkers that can be used as an adjunct test to imaging diagnosis to improve patient follow-up.
CONDITIONS
Official Title
Biomarker Discovery in Lung Cancer - Malaysia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female subjects aged 30 and above
- No previous history of any cancers
- Able to provide X-ray and/or LDCT results
- Have either COPD or pulmonary nodules measuring less than 11mm, or deemed not for biopsy by attending physician
- Willing to go back for a follow-up X-ray or LDCT scan in the next clinical follow up as per standard of care
- Willing to provide up to 30mL of blood in month-0 (first visit) and up to 21mL in the next standard of care follow up visit (second visit)
You will not qualify if you...
- Subject has received chemotherapy or radiotherapy for cancer treatment, and any other cancer-related treatment
- Subject is pregnant or lactating (self-declaration)
- Subject is unwilling or unable to provide signed informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Malaya Medical Centre
Kuala Lumpur, Malaysia, 59100
Actively Recruiting
Research Team
M
Mau Ern Poh
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here